Results 151 to 160 of about 13,872 (226)

Selpercatinib in the treatment of thyroid cancer. [PDF]

Future Oncol
Gauduchon T, Varnier R, Cassier PA.
europepmc   +1 more source

Real-world clinical responses to selpercatinib in RET M918T-mutant medullary thyroid carcinoma. [PDF]

Discov Oncol
Ökten IN, Baydaş T.
europepmc   +1 more source

Highlights of ASCO 2026. [PDF]

Oncologist
DaSilva BA, Neugut AI, Fojo T, Bates SE.
europepmc   +1 more source

Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report. [PDF]

Medicine (Baltimore)
Breitenecker K, Fabikan H, Weinlinger C, Krenbek D, Klikovits T, Watzka S, Valipour A, Hochmair MJ.   +7 more
europepmc   +1 more source

Brain metastasis: Opportunities for novel therapies. [PDF]

Neurotherapeutics
Sarfraz Z, Kotecha R, Maharaj A, Ahluwalia MS.   +3 more
europepmc   +1 more source

Jerome Cornfield: Some Memories. [PDF]

Obs Stud
Ellenberg SS.
europepmc   +1 more source

An Uncommon Presentation of Selpercatinib (Retevmo)-Induced Severe Transaminitis: A Biopsy-Proven Case Report. [PDF]

Cureus
Biswas N, Dudhia K.
europepmc   +1 more source

Durable Response to Selpercatinib in Metastatic Colorectal Cancer Harboring a Novel <i>TIMM23B::RET</i> Fusion: A Case Report. [PDF]

Curr Oncol
Tong Z, Yang M, Weng S, Yuan Y.
europepmc   +1 more source

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: <i>How to manage thyroid diseases: from autoimmunity to malignancy</i> Special Issue. [PDF]

Drugs Context
Saltiki K, Effraimidis G.
europepmc   +1 more source

Selpercatinib for RET fusion-positive non-small cell lung cancer. [PDF]

Aust Prescr
europepmc   +1 more source